Holen Sie sich die Stockscreener-App
20.96
0.73%
-0.33
Schlusskurs vom Vortag:
$21.29
Offen:
$21.14
24-Stunden-Volumen:
12,851
Relative Volume:
0.02
Marktkapitalisierung:
$1.07B
Einnahmen:
$379.81M
Nettoeinkommen (Verlust:
$-21.35M
KGV:
-53.16
EPS:
-0.3943
Netto-Cashflow:
$35.44M
1W Leistung:
+20.29%
1M Leistung:
+23.24%
6M Leistung:
+45.01%
1J Leistung:
+18.91%
1-Tages-Spanne:
$20.84
$21.18
1-Wochen-Bereich:
$20.10
$23.24
52-Wochen-Spanne:
$10.96
$23.24
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
20.96 | 1.06B | 379.81M | -21.35M | 35.44M | -0.3943 |
TMO
Thermo Fisher Scientific Inc
|
528.02 | 194.94B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.46 | 137.69B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
573.00 | 45.19B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.95 | 34.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
337.57 | 32.91B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting - BioSpace
Keith Kennedy to Assume Dual Role at CareDx - Medical Product Outsourcing
CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing - TradingView
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx CEO John Hanna Jr. sells $217,155 in company stock - Investing.com
CareDx (CDNA) CEO sells 10,282 shares at $21.12 under Rule 10b5-1 plan - Stock Titan
CareDx (CDNA) to Sell Lab Products Division to EuroBio Scientifi - GuruFocus
CareDx (CDNA) Launches Innovative AlloSeq Nano Genotyping Soluti - GuruFocus
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing - BioSpace
CareDx sharpens focus on core testing services - MSN
Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns - Yahoo Finance
CareDx: Watch For Profit-Taking After Recent Positive Preliminary Q1 Results - Seeking Alpha
All You Need to Know About CareDx (CDNA) Rating Upgrade to Buy - Yahoo Finance
Analysts Conflicted on These Healthcare Names: CareDx (CDNA) and Pfizer (PFE) - The Globe and Mail
Are Medical Stocks Lagging CareCloud (CCLD) This Year? - Yahoo! Finance Canada
Sumitomo Mitsui Trust Group Inc. Trims Stake in CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (CDNA) Stock Analysis: Exploring Growth Potential And Analyst Consensus - DirectorsTalk Interviews
CareDx Sharpens Focus On Core Testing Services - Sahm
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments By Investing.com - Investing.com Australia
CareDx Inc (CDNA) Shares Surge 27.6% -- What GF Score of 80 Tells Investors - GuruFocus
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments - Investing.com
Proposed CDNA common sales; John Hanna 10b5-1 trades (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) CEO has 62,049 shares withheld to cover RSU tax bill - Stock Titan
CareDx Up 28%, on Track for Largest Percent Increase Since May 2024 -- Data Talk - 富途牛牛
CareDx Sharpens Focus On Core Testing Services - Benzinga
CareDx (NASDAQ:CDNA) Reaches New 1-Year HighHere's Why - MarketBeat
CareDx Sells Lab Products Business to EuroBio Scientific for $170 Million, Reports 48% Growth in Testing Services Revenue - Minichart
Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday - Benzinga
CareDx Divests Lab Products to Refocus on Core Growth - TipRanks
CDNA Reports 17% Increase in Q1 Testing Service Volume - GuruFocus
CareDx (NASDAQ: CDNA) divests Lab Products business in $170M Eurobio deal - Stock Titan
Eurobio scientific signs definitive agreement to acquire CareDx’s transplant Lab Product division - marketscreener.com
CareDx (CDNA) Soars After Divestiture Announcement and Strong Re - GuruFocus
CareDx (CDNA) Sells Lab Products Division for $170M - GuruFocus
CareDx to sell lab products unit for $170 million in cash - Investing.com India
BTIG Maintains CareDx (CDNA) Buy Recommendation - MSN
CareDx Divests Lab Products Business for $170M, Focuses on Precision Medicine Testing - National Today
(CDNA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Caredx announces agreement to divest lab products business to Eurobio Scientific for $170 million and announces first quarter preliminary financial results - marketscreener.com
CareDx (CDNA) Sees 20% Surge Following Q1 Pre-Announcement - GuruFocus
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results - Business Wire
CareDx and Omada Health Compared: Which Medical Stock Stands Out? - National Today
CareDx (CDNA) Q4 Earnings Miss Estimates - Eastern Progress
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - BioSpace
How The CareDx (CDNA) Investment Story Is Shifting With New Targets And Policy Risks - Yahoo Finance
CareDx to sell lab products unit for $170 million in cash By Investing.com - Investing.com South Africa
Fenwick Represents CareDX in Divestiture of Lab Products Business to EuroBio Scientific - fenwick.com
Eurobio Scientific Société anonyme entered into a definitive agreement to acquire Caredx AB and Kitted Laboratory Products Business and Related Software of CareDx, Inc. for $170 million. - marketscreener.com
Press Release: CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - 富途牛牛
Aug PreEarnings: Whats the RSI of CareDx Inc stockMarket Trend Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Book value per share of CareDx, Inc. – DUS:1K9 - TradingView — Track All Markets
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.26%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):